Skip to main content
. 2021 Sep 20;13(9):1878. doi: 10.3390/v13091878

Figure 4.

Figure 4

Maternal ZIKV infection characteristics and neutralizing antibody responses. (A) Plasma viremia curves for individual animals, denoted by different lines for each animal. Dashed line is the limit of quantification. (B) Duration of viremia, from the day of inoculation until the last day of a positive plasma viral load (t-test, p-value = 0.4638). (C) Proportion of dams within each group with viremia duration greater or less than 21 days (t-test, p-value = 0.2657). (D) Peak viral plasma loads, defined as the highest plasma vRNA titer (t-test, p-value = 0.4208). (E) DENV PRNT90 on the day of ZIKV inoculation (ZIKV-only animals not tested). (F) ZIKV PRNT90 at 28 days post-ZIKV inoculation (control animals not tested). (G) ZIKV vRNA distribution within the maternal–fetal interface, displayed as the proportion of cotyledons with a positive viral load.